For instance, AMD3100, a specific CXCR4 antagonist, enhances the efficacy of chemotherapy by inhibiting SDF1-CXCR4, facilitating the entry of leukemia cells into the cell cycle (135). This evidence concerns the gene CXCL12 and leukemia.